Aligos posts Phase 1 results for ALG-097558 in hepatic impairment studyAug 5Trial updateALG-097558Aligos Therapeutics
Aligos posts results for ALG-097558 renal impairment PK study, trial completedJul 9Trial updateALG-097558Aligos Therapeutics